Yilmaz, A. Et Al. 2016. Reduced BCL2 and CCND1 mRNA expression in human cervical cancer HeLa cells treated with a combination of everolimus and paclitaxel. WSPOLCZESNA ONKOLOGIA-CONTEMPORARY ONCOLOGY , vol.20, no.1 , 28-32.

Yilmaz, A., Alp, E., ÖNEN, H. İ., & Menevse, S., (2016). Reduced BCL2 and CCND1 mRNA expression in human cervical cancer HeLa cells treated with a combination of everolimus and paclitaxel. WSPOLCZESNA ONKOLOGIA-CONTEMPORARY ONCOLOGY , vol.20, no.1, 28-32.

Yilmaz, Akin Et Al. "Reduced BCL2 and CCND1 mRNA expression in human cervical cancer HeLa cells treated with a combination of everolimus and paclitaxel," WSPOLCZESNA ONKOLOGIA-CONTEMPORARY ONCOLOGY , vol.20, no.1, 28-32, 2016

Yilmaz, Akin Et Al. "Reduced BCL2 and CCND1 mRNA expression in human cervical cancer HeLa cells treated with a combination of everolimus and paclitaxel." WSPOLCZESNA ONKOLOGIA-CONTEMPORARY ONCOLOGY , vol.20, no.1, pp.28-32, 2016

Yilmaz, A. Et Al. (2016) . "Reduced BCL2 and CCND1 mRNA expression in human cervical cancer HeLa cells treated with a combination of everolimus and paclitaxel." WSPOLCZESNA ONKOLOGIA-CONTEMPORARY ONCOLOGY , vol.20, no.1, pp.28-32.

@article{article, author={Akin Yilmaz Et Al. }, title={Reduced BCL2 and CCND1 mRNA expression in human cervical cancer HeLa cells treated with a combination of everolimus and paclitaxel}, journal={WSPOLCZESNA ONKOLOGIA-CONTEMPORARY ONCOLOGY}, year=2016, pages={28-32} }